Quality of life, at what cost?
Oubre
David N
DN
D018906:Antineoplastic Agents, Alkylating / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs / Q000706:statistics & numerical data*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000191:economics / Q000473:pathology; D011788:Quality of Life; D012878:Skin Neoplasms / Q000188:drug therapy / Q000191:economics / Q000473:pathology; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide